Page 311 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 311

Systemic Vasculitis of the Gastrointestinal Tract                         285

Table 6. Clinical Features of Polyarteritis Nodosa*

  Manifestation                Specific Problems                          Frequency (%)
  Systemic symptoms            Fever, malaise, weight loss                80
  Neuropathy                   Mononeuritis multiplex, polyneuropathy     75
  Arthralgia and / or myalgia  Articular and / or diffuse extremity pain  60
  Cutaneous                    Livedo reticularis, purpura, ulcers        50
  Renal disease                Elevated creatinine, hematuria,            50
                               glomerulonephritis
  Gastrointestinal symptoms    Abdominal pain, rectal bleeding            40
  Hypertension                 New onset                                  35
  Respiratory manifestations   Infiltrates, nodules, cavities             25
  Central nervous system       Stroke, confusion                          20
  disease
  Orchitis                     Testicular pain, swelling                  20
  Cardiac involvement          Cardiomyopathy, pericarditis               10
  Peripheral vascular disease  Claudication, ischemia, necrosis           10
*Adapted from [46].

Gastrointestinal Involvement
     Gastrointestinal involvement occurs in 40% to 65% of patients with PAN. Abdominal

pain is the commonest reported GI symptom in PAN. Gastrointestinal involvement can arise
from stenotic lesions that lead to bowel wall ischemia and aneurysm formation that results in
hemorrhage. Necrosis of the bowel wall with the potential for subsequent perforation can
develop if systemic inflammation gives rise to transmural ischemia and confers a poor
prognosis [51]. Gastrointestinal manifestations of PAN include ulceration, obstruction,
infarction, perforation and hemorrhage that can affect the stomach, small bowel, large bowel
and the appendix [53-55]. A retrospective analysis of 54 patients with PAN found GI
involvement in 24 (44%) with two-thirds noting abdominal pain at presentation, while all
others had abdominal pain at some point in their illness. About one-half of patients developed
acute abdomen with associated diagnoses of bowel infarction and perforation and less
commonly acute cholecystitis, gall bladder infarction, aneurysmal ruptures of hepatic, splenic
or renal arteries, and bleeding from perforated gastric ulcers [56]. Multiple aneurysm
formation is a defining feature of PAN so noted in 50% to 70% of those with involvement of
the GI tract with the hepatic artery affected in 50% to 60%; splenic artery in 45%; and
pancreatic artery in 25 to 35% [56-58]. Massive internal hemorrhage due to rupture of an
aneurysm within the intestine is rare but nonetheless carries a high mortality (75%) [58-60].

Treatment
     The mainstay of treatment for mild PAN is corticosteroids however gastrointestinal

involvement usually necessitates treatment with cyclophosphamide, as it constitutes severe
disease and has been shown to have a better outcome when treated with a combination of
cyclophosphamide and corticosteroids [61]. PAN secondary to HBV infection is treated with
two weeks of corticosteroids followed by antiviral treatment combined with plasma exchange.
Those so treated with antiviral medication do not experience HBV relapses once viral
replication has stopped and seroconversion has been achieved [50]. Occlusive mesenteric

            Complimentary Contributor Copy
   306   307   308   309   310   311   312   313   314   315   316